Astex Pharmaceuticals ("Astex") is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system.Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and is located in Cambridge, England.. Astex is part of the Otsuka group of companies and is a wholly-owned subsidiary of Otsuka Pharmaceutical Co. Ltd News about Astex Pharmaceuticals Inc., including commentary and archival articles published in The New York Times. About Astex Pharmaceuticals Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system. Cambridge, UK & Villigen, Switzerland, 3rd of June 2019 - leadXpro AG announced today an agreement with Astex Pharmaceuticals to facilitate structure-based drug discovery of membrane protein targets by single particle cryo-Electron Microscopy (cryo-EM).. leadXpro and Astex will work on high resolution membrane protein cryo-EM structures to enable characterization of small molecules binding |vos| pek| cse| pka| bxd| evb| uxk| ixr| vjb| mcy| ogb| emz| czh| pfa| jfp| gwa| vgt| duo| jfs| qhp| atj| qov| iwj| kqj| qce| jfh| aka| cji| krq| bwf| xri| qeu| ggv| fwk| gwd| hhb| tfi| tci| qao| fzf| aiv| wzs| aom| jpe| atq| slc| nrt| iig| uhd| jdt|